Clinical trial
A Seamless Phase I/IIa Clinical Study to Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
NCT05532943 is registered in ClinicalTrials.gov with Ever Supreme Bio Technology Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Seamless Phase I/IIa Clinical Study to Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
- Lead sponsor
- Ever Supreme Bio Technology Co., Ltd.
- Phase
- Phase 1/2
- Overall status
- Recruiting
- Start date
- September 8, 2023
- Completion date
- October 31, 2028
- Enrollment
- 41 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.